{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T13:30:17Z","timestamp":1655299817201},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T00:00:00Z","timestamp":1426204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s00432-015-1952-z","type":"journal-article","created":{"date-parts":[[2015,3,12]],"date-time":"2015-03-12T19:33:46Z","timestamp":1426188826000},"page":"1503-1509","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myeloma"],"prefix":"10.1007","volume":"141","author":[{"given":"Michael G.","family":"Alexandrakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis K.","family":"Neonakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantina A.","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Konsolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Kokonozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodanthi","family":"Vyzoukaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Soundoulounaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athina","family":"Xekalou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katerina","family":"Sfiridaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Tsirakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,13]]},"reference":[{"key":"1952_CR1","author":"MG Alexandrakis","year":"2014","unstructured":"Alexandrakis MG, Tsirakis G (2014) Circulating levels of soluble angiogenic factors in multiple myeloma: correlation with parameters of disease activity and prognosis. Curr Angiogenesis. doi: 10.2174\/22115528113026660012","journal-title":"Curr Angiogenesis"},{"issue":"8","key":"1952_CR2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jcp.2003.013110","volume":"57","author":"MG Alexandrakis","year":"2004","unstructured":"Alexandrakis MG, Passam FH, Dambaki C, Pappa CA, Stathopoulos EN (2004a) The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma. J Clin Pathol 57(8):856\u2013860","journal-title":"J Clin Pathol"},{"issue":"10","key":"1952_CR3","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1515\/CCLM.2004.230","volume":"42","author":"MG Alexandrakis","year":"2004","unstructured":"Alexandrakis MG, Passam FJ, Ganotakis E, Dafnis E, Dambaki C, Konsolas J et al (2004b) Bone marrow microvascular density and angiogenic growth factors in multiple myeloma. Clin Chem Lab Med 42(10):1122\u20131126","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"1952_CR4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/039463200401700107","volume":"17","author":"MG Alexandrakis","year":"2004","unstructured":"Alexandrakis MG, Passam FH, Pappa CA, Dambaki C, Sfakiotaki G, Alegakis AK et al (2004c) Expression of proliferating cell nuclear antigen (PCNA) in multiple myeloma: its relationship to bone marrow microvessel density and other factors of disease activity. Int J Immunopathol Pharmacol 17(1):49\u201356","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"10","key":"1952_CR5","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbadis.2009.07.003","volume":"1792","author":"C Bernabeu","year":"2009","unstructured":"Bernabeu C, Lopez-Novoa JM, Quintanilla M (2009) The emerging role of TGF-beta superfamily coreceptors in cancer. Biochim Biophys Acta 1792(10):954\u2013973","journal-title":"Biochim Biophys Acta"},{"key":"1952_CR6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ajh.20639","volume":"81","author":"SS Bhatti","year":"2006","unstructured":"Bhatti SS, Kumar L, Dinda AK, Dawar R (2006) Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters. Am J Hematol 81:649\u2013656","journal-title":"Am J Hematol"},{"key":"1952_CR7","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1096\/fj.02-0634rev","volume":"17","author":"SE Duff","year":"2003","unstructured":"Duff SE, Li C, Garland JM, Kumar S (2003) CD105 is important for angiogenesis: evidence and potential applications. FASEB J 17:984\u2013992","journal-title":"FASEB J"},{"key":"1952_CR8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/hon.738","volume":"22","author":"E Hatjiharissi","year":"2004","unstructured":"Hatjiharissi E, Terpos E, Papaioannou M, Hatjileontis C, Kaloutsi V, Galaktidou G et al (2004) The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory\/relapsed multiple myeloma. Hematol Oncol 22:159\u2013168","journal-title":"Hematol Oncol"},{"key":"1952_CR9","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/onc.2010.488","volume":"30","author":"LA Henry","year":"2011","unstructured":"Henry LA, Johnson DA, Sarrio D, Lee S, Quinlan PR, Crook T et al (2011) Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome. Oncogene 30:1046\u20131058","journal-title":"Oncogene"},{"key":"1952_CR10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1158\/1078-0432.CCR-06-0061","volume":"13","author":"J Hillengass","year":"2007","unstructured":"Hillengass J, Wasser K, Delorme S, Kiessling F, Zechmann C, Benner A, Kauczor HU, Ho AD, Goldschmidt H, Moehler TM (2007) Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma. Clin Cancer Res 13:475\u2013481","journal-title":"Clin Cancer Res"},{"key":"1952_CR11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1365-2141.2002.03871.x","volume":"119","author":"S Kumar","year":"2002","unstructured":"Kumar S, Fonseca R, Dispenzieri A, Lacy MQ, Lust JA, Witzig TE et al (2002) Bone marrow angiogenesis in multiple myeloma: effect of therapy. Br J Haematol 119:665\u2013671","journal-title":"Br J Haematol"},{"key":"1952_CR12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/sj.bmt.1704555","volume":"34","author":"S Kumar","year":"2004","unstructured":"Kumar S, Gertz MA, Dispenzieri A, Lacy MQ, Wellik LA, Fonseca R (2004a) Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy. Bone Marrow Transplant 34:235\u2013239","journal-title":"Bone Marrow Transplant"},{"key":"1952_CR13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/sj.leu.2403285","volume":"18","author":"S Kumar","year":"2004","unstructured":"Kumar S, Witzig TE, Dispenzieri A, Lacy MQ, Wellik LE, Fonseca R et al (2004b) Effect of thalidomide therapy on bone marrow angiogenesis in multiple myeloma. Leukemia 18:624\u2013627","journal-title":"Leukemia"},{"key":"1952_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10585-010-9356-6","volume":"28","author":"M Lakshman","year":"2011","unstructured":"Lakshman M, Huang X, Ananthanarayanan V, Jovanovic B, Liu Y, Craft CS (2011) Endoglin suppresses human prostate cancer metastasis. Clin Exp Metastasis 28:39\u201353","journal-title":"Clin Exp Metastasis"},{"key":"1952_CR16","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V87.3.1056.bloodjournal8731056","volume":"87","author":"T Menzel","year":"1996","unstructured":"Menzel T, Rahman Z, Calleja E, White K, Wilson EL, Wieder R et al (1996) Elevated intracellular level of basic fibroblast growth factor correlates with stage of chronic lymphocytic leukemia and is associated with resistance to fludarabine. Blood 87:1056\u20131063","journal-title":"Blood"},{"key":"1952_CR17","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/leu.2010.70","volume":"24","author":"LA Moulopoulos","year":"2010","unstructured":"Moulopoulos LA, Dimopoulos MA, Christoulas D, Kastritis E, Anagnostou D, Koureas A et al (2010) Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents. Leukemia 24:1206\u20131212","journal-title":"Leukemia"},{"key":"1952_CR18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0093-7754(01)90025-9","volume":"28","author":"NC Munshi","year":"2001","unstructured":"Munshi NC, Wilson C (2001) Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis. Semin Oncol 28:565\u2013569","journal-title":"Semin Oncol"},{"key":"1952_CR19","first-page":"2283","volume":"31","author":"F Nassiri","year":"2011","unstructured":"Nassiri F, Cusimano MD, Scheithauer BW, Rotondo F, Fazio A, Yousef GM et al (2011) Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy. Anticancer Res 31:2283\u20132290","journal-title":"Anticancer Res"},{"key":"1952_CR20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12185-011-0963-z","volume":"94","author":"E Otjacques","year":"2011","unstructured":"Otjacques E, Binsfeld M, Noel A, Beguin Y, Cataldo D, Caers J (2011) Biological aspects of angiogenesis in multiple myeloma. Int J Hematol 94:505\u2013518","journal-title":"Int J Hematol"},{"key":"1952_CR21","author":"C Pappa","year":"2013","unstructured":"Pappa C, Alexandrakis M, Boula A, Psarakis F, Kolovou A, Bantouna V et al (2013) Emerging roles of endoglin\/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients. Hematol Oncol. doi: 10.1002\/hon.2044","journal-title":"Hematol Oncol"},{"key":"1952_CR22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1365-2141.2002.03654.x","volume":"118","author":"G Pruneri","year":"2002","unstructured":"Pruneri G, Ponzoni M, Ferreri AJ, Decarli N, Tresoldi M, Raggi F et al (2002) Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients. Br J Haematol 118:817\u2013820","journal-title":"Br J Haematol"},{"key":"1952_CR23","first-page":"2210","volume":"8","author":"SV Rajkumar","year":"2002","unstructured":"Rajkumar SV, Mesa RA, Fonseca R, Schroeder G, Plevak MF, Dispenzieri A et al (2002) Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res 8:2210\u20132216","journal-title":"Clin Cancer Res"},{"key":"1952_CR24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jcp.20878","volume":"210","author":"JF Santibanez","year":"2007","unstructured":"Santibanez JF, Letamendia A, Perez-Barriocanal F, Silvestri C, Saura M, Vary CP et al (2007) Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-beta signaling. J Cell Physiol 210:456\u2013468","journal-title":"J Cell Physiol"},{"key":"1952_CR25","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s002770100361","volume":"80","author":"O Sezer","year":"2001","unstructured":"Sezer O, Niem\u00f6ller K, Jakob C, Zavrski I, Heider U, Eucker J et al (2001a) Relationship between bone marrow angiogenesis and plasma cell infiltration and serum beta2-microglobulin levels in patients with multiple myeloma. Ann Hematol 80:598\u2013601","journal-title":"Ann Hematol"},{"key":"1952_CR26","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1034\/j.1600-0609.2001.066004238.x","volume":"66","author":"O Sezer","year":"2001","unstructured":"Sezer O, Niem\u00f6ller K, Kaufmann O, Eucker J, Jakob C, Zavrski I et al (2001b) Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy. Eur J Haematol 66:238\u2013244","journal-title":"Eur J Haematol"},{"key":"1952_CR27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/hon.1014","volume":"30","author":"G Tsirakis","year":"2012","unstructured":"Tsirakis G, Pappa CA, Kanellou P, Stratinaki MA, Xekalou A, Psarakis FE et al (2012a) Role of platelet-derived growth factor-AB in tumour growth and angiogenesis in relation with other angiogenic cytokines in multiple myeloma. Hematol Oncol 30:131\u2013136","journal-title":"Hematol Oncol"},{"key":"1952_CR28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejim.2012.01.012","volume":"23","author":"G Tsirakis","year":"2012","unstructured":"Tsirakis G, Pappa CA, Spanoudakis M, Chochlakis D, Alegakis A, Psarakis FE et al (2012b) Clinical significance of sCD105 in angiogenesis and disease activity in multiple myeloma. Eur J Intern Med 23:368\u2013373","journal-title":"Eur J Intern Med"},{"key":"1952_CR29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","volume":"87","author":"A Vacca","year":"1994","unstructured":"Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F et al (1994) marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87:503\u2013508","journal-title":"Br J Haematol"},{"key":"1952_CR30","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/ijc.23882","volume":"123","author":"VC Wong","year":"2008","unstructured":"Wong VC, Chan PL, Bernabeu C, Law S, Wang LD, Li JL et al (2008) Identification of an invasion and tumor-suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma. Int J Cancer 123:2816\u20132823","journal-title":"Int J Cancer"},{"key":"1952_CR31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cyto.b.21083","volume":"84","author":"W Zheng","year":"2013","unstructured":"Zheng W, Liu D, Fan X, Powers L, Goswami M, Hu Y et al (2013) Potential therapeutic biomarkers in plasma cell myeloma: a flow cytometry study. Cytom B Clin Cytom 84:222\u2013228","journal-title":"Cytom B Clin Cytom"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-015-1952-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-015-1952-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-015-1952-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T20:01:04Z","timestamp":1598817664000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-015-1952-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,13]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["1952"],"URL":"https:\/\/doi.org\/10.1007\/s00432-015-1952-z","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,13]]}}}